Investments
159Portfolio Exits
37Funds
5About Prospect Venture Partners
Prospect Venture Partners is a Palo Alto, California based venture capital firm with over $1B of capital under management. The firm is dedicated to investing in biopharmaceutical and medical device companies. The firm invests in companies with a wide variety of development and financing requirements including new company incubations, first and second venture financing rounds, and later stage private and public companies with proven business models requiring expansion capital. Prospect Venture Partners seeks to ultimately invest $10-$20 million in each company as a lead investor or as a co-lead in an investor syndicate. First round investments generally range from $500,000 to $10 million. Prospect Venture Partners typically has representation on the board of each of its portfolio companies, and serves as an active partner.
Want to inform investors similar to Prospect Venture Partners about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Prospect Venture Partners News
Aug 1, 2019
She is responsible for finance, legal, information technology, human resources, and internal operations. Lori was formerly Chief Financial Officer of Prospect Venture Partners where her responsibilities included managing operations, accounting, budgeting, financial reporting, and portfolio company investment modeling. Prior to Prospect, Lori served as Director of Finance for Opus Capital, Director of Finance for Lightspeed Venture Partners, and served a broad array of venture capital firms in her capacity as Western Region Project Manager for Analytx, Inc. Interests: Skiing, golfing, and travelling. Links
Prospect Venture Partners Investments
159 Investments
Prospect Venture Partners has made 159 investments. Their latest investment was in Chronic Care Management as part of their Unattributed VC on August 8, 2022.
Prospect Venture Partners Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
8/22/2022 | Unattributed VC | Chronic Care Management | $6.39M | Yes | 1 | |
3/24/2022 | Series C | Post Acute Analytics | $3M | Yes | 2 | |
1/23/2019 | Series A | Third Eye Health | $7.25M | Yes | 1 | |
9/27/2016 | Series D | |||||
11/25/2015 | Series C |
Date | 8/22/2022 | 3/24/2022 | 1/23/2019 | 9/27/2016 | 11/25/2015 |
|---|---|---|---|---|---|
Round | Unattributed VC | Series C | Series A | Series D | Series C |
Company | Chronic Care Management | Post Acute Analytics | Third Eye Health | ||
Amount | $6.39M | $3M | $7.25M | ||
New? | Yes | Yes | Yes | ||
Co-Investors | |||||
Sources | 1 | 2 | 1 |
Prospect Venture Partners Portfolio Exits
37 Portfolio Exits
Prospect Venture Partners has 37 portfolio exits. Their latest portfolio exit was Helsinn on August 06, 2021.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
8/6/2021 | Acquired | 2 | |||
8/12/2019 | Acquired | 5 | |||
6/18/2019 | Acquired | 3 | |||
Date | 8/6/2021 | 8/12/2019 | 6/18/2019 | ||
|---|---|---|---|---|---|
Exit | Acquired | Acquired | Acquired | ||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources | 2 | 5 | 3 |
Prospect Venture Partners Acquisitions
1 Acquisition
Prospect Venture Partners acquired 1 company. Their latest acquisition was Patient Care on August 20, 2008.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
8/20/2008 | Acquired |
Date | 8/20/2008 |
|---|---|
Investment Stage | |
Companies | |
Valuation | |
Total Funding | |
Note | Acquired |
Sources |
Prospect Venture Partners Fund History
5 Fund Histories
Prospect Venture Partners has 5 funds, including Prospect Venture Partners IV LP.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
8/18/2010 | Prospect Venture Partners IV LP | Early-Stage Venture Capital | Withdrawn | $150M | 1 |
11/30/2004 | Prospect Venture Partners III LP | ||||
2/8/2002 | Prospect Associates II | ||||
7/20/2001 | Prospect Venture Partners II LP | ||||
4/30/1998 | Prospect Venture Partners LP |
Closing Date | 8/18/2010 | 11/30/2004 | 2/8/2002 | 7/20/2001 | 4/30/1998 |
|---|---|---|---|---|---|
Fund | Prospect Venture Partners IV LP | Prospect Venture Partners III LP | Prospect Associates II | Prospect Venture Partners II LP | Prospect Venture Partners LP |
Fund Type | Early-Stage Venture Capital | ||||
Status | Withdrawn | ||||
Amount | $150M | ||||
Sources | 1 |
Prospect Venture Partners Team
11 Team Members
Prospect Venture Partners has 11 team members, including , .
Name | Work History | Title | Status |
|---|---|---|---|
Jim Tananbaum | Founder | Current | |
Name | Jim Tananbaum | ||||
|---|---|---|---|---|---|
Work History | |||||
Title | Founder | ||||
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.